Urology
Volume 73, Issue 3 , Pages 473-475 , March 2009

Brachytherapy for Localized Prostate Cancer

  • Jay P. Ciezki, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Jay P. Ciezki, M.D., Department of Radiation Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195

Received 18 April 2008 ,Accepted 17 July 2008.

References 

  1. National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology, version 2.2007 prostate cancer. http://www.nccn.org/professionals/physicians_gls/PDFprostate.pdfAccessed April 9, 2007.
  2. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261
  3. Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007;67:327–333
  4. Vicini FA, Martinez A, Hanks G, et al. An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up. Cancer. 2002;95:2126–2135
  5. Cox J, Grignon D, Kaplan R, et al. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1035–1041
  6. Roach M, Hanks G, Thames H, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys. 2006;65:965–974
  7. Ciezki JP, Klein EA, Angermeier K, et al. A retrospective comparison of the use of androgen deprivation among low and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004;60:1347–1350
  8. Wong Y, Mitra N, Hudes G, et al. Survival associated with treatment vs. observation of localized prostate cancer in elderly men. JAMA. 2006;296:2683–2693
  9. Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:25–33
  10. Kupelian PA, Thakkar VV, Khuntia D, et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys. 2005;63:1463–1468

PII: S0090-4295(08)01601-4

doi: 10.1016/j.urology.2008.07.070

Urology
Volume 73, Issue 3 , Pages 473-475 , March 2009

Article Tools